SARS-CoV-2 Infection

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19